Ad hoc: Evotec and Bristol Myers Squibb expand strategic neurodegeneration partnership

 
Hamburg, Germany – Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE 000 566480 9, WKN 566480; NASDAQ: EVO) announces today that the Company has extended and expanded its strategic partnership with …

Read More